ResMed Aktie
209,80
EUR
+3,20
EUR
+1,55
%
239,91
USD
+3,44
USD
+1,45
%
Werbung
ResMed Aktie Analyse
25.09.17 | ResMed Underweight | Barclays Capital | |
07.04.16 | ResMed Underweight | Barclays Capital | |
27.01.15 | ResMed Under Perform | Northland Capital |
Werbung
Werbung